Bank of New Hampshire Decreases Holdings in The Procter & Gamble Company (NYSE:PG)

Bank of New Hampshire lessened its position in shares of The Procter & Gamble Company (NYSE:PG) by 1.3% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 21,586 shares of the company’s stock after selling 275 shares during the quarter. Procter & Gamble accounts for 0.9% of Bank of New Hampshire’s portfolio, making the stock its 28th biggest holding. Bank of New Hampshire’s holdings in Procter & Gamble were worth $3,619,000 at the end of the most recent reporting period.

A number of other institutional investors also recently bought and sold shares of the company. International Assets Investment Management LLC grew its stake in shares of Procter & Gamble by 19,030.8% during the 3rd quarter. International Assets Investment Management LLC now owns 3,693,593 shares of the company’s stock valued at $639,730,000 after acquiring an additional 3,674,286 shares during the period. Wulff Hansen & CO. lifted its holdings in Procter & Gamble by 16,292.0% during the second quarter. Wulff Hansen & CO. now owns 3,675,902 shares of the company’s stock valued at $606,230,000 after purchasing an additional 3,653,477 shares in the last quarter. Geode Capital Management LLC boosted its position in shares of Procter & Gamble by 7.0% in the third quarter. Geode Capital Management LLC now owns 55,204,776 shares of the company’s stock worth $9,538,327,000 after purchasing an additional 3,619,466 shares during the period. Franklin Resources Inc. increased its stake in shares of Procter & Gamble by 10.2% in the third quarter. Franklin Resources Inc. now owns 18,988,721 shares of the company’s stock worth $3,290,573,000 after purchasing an additional 1,760,214 shares in the last quarter. Finally, B. Metzler seel. Sohn & Co. Holding AG purchased a new position in shares of Procter & Gamble during the 3rd quarter valued at $301,950,000. Institutional investors own 65.77% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have commented on PG shares. Morgan Stanley raised their price target on Procter & Gamble from $174.00 to $191.00 and gave the company an “overweight” rating in a report on Monday, October 21st. Barclays cut Procter & Gamble from an “overweight” rating to an “equal weight” rating and set a $163.00 price target on the stock. in a report on Monday, September 30th. JPMorgan Chase & Co. boosted their target price on shares of Procter & Gamble from $179.00 to $186.00 and gave the stock an “overweight” rating in a report on Thursday, September 19th. Royal Bank of Canada reaffirmed a “sector perform” rating and set a $164.00 target price on shares of Procter & Gamble in a research note on Monday, October 21st. Finally, Wells Fargo & Company increased their price objective on shares of Procter & Gamble from $188.00 to $190.00 and gave the company an “overweight” rating in a report on Friday, November 22nd. Eight analysts have rated the stock with a hold rating, fourteen have assigned a buy rating and two have assigned a strong buy rating to the stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average price target of $180.45.

Procter & Gamble Stock Performance

Shares of PG stock traded up $1.46 during mid-day trading on Tuesday, reaching $162.06. The stock had a trading volume of 732,199 shares, compared to its average volume of 5,015,155. The business’s fifty day moving average is $170.03 and its 200-day moving average is $169.80. The firm has a market cap of $381.66 billion, a price-to-earnings ratio of 27.94, a PEG ratio of 3.70 and a beta of 0.45. The Procter & Gamble Company has a 1-year low of $146.28 and a 1-year high of $180.43. The company has a current ratio of 0.75, a quick ratio of 0.55 and a debt-to-equity ratio of 0.50.

Procter & Gamble (NYSE:PG) last posted its earnings results on Friday, October 18th. The company reported $1.93 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.90 by $0.03. Procter & Gamble had a net margin of 17.07% and a return on equity of 33.25%. The firm had revenue of $21.74 billion during the quarter, compared to analysts’ expectations of $21.99 billion. During the same period in the previous year, the business posted $1.83 EPS. The business’s revenue was down .6% compared to the same quarter last year. On average, research analysts forecast that The Procter & Gamble Company will post 6.94 earnings per share for the current year.

Insider Transactions at Procter & Gamble

In related news, CEO R. Alexandra Keith sold 1,992 shares of the stock in a transaction on Tuesday, October 22nd. The stock was sold at an average price of $170.00, for a total value of $338,640.00. Following the completion of the transaction, the chief executive officer now directly owns 13,783 shares of the company’s stock, valued at approximately $2,343,110. This represents a 12.63 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Balaji Purushothaman sold 12,800 shares of the stock in a transaction dated Thursday, October 24th. The shares were sold at an average price of $168.99, for a total transaction of $2,163,072.00. Following the completion of the sale, the insider now owns 11,566 shares of the company’s stock, valued at $1,954,538.34. This trade represents a 52.53 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 75,439 shares of company stock valued at $13,317,460 in the last three months. 0.18% of the stock is currently owned by company insiders.

About Procter & Gamble

The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.